March 02, 2023
A New Jersey judge largely refused to toss a lawsuit accusing Amarin Pharma of hoarding the active pharmaceutical ingredients needed to produce generic versions of its cardiovascular drug Vascepa, finding that it was possible Amarin acted in bad faith.